Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Cachexia × Pentoxifylline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

HIV Infections 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Cachexia 1 Acquired Immunodeficiency Syndrome 1

Interventions

testosterone enanthate 1 remune 1 olanzapine-fluoxetine combination 1 irinotecan sucrosofate 1 bermekimab 1 Pentoxifylline 1 Olanzapine 1 Fluoxetine 1 Fluorouracil 1 Exercise 1 Cannabidiol 1 Adenosine Triphosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00000646 2021-11-02

Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed

Acquired Immunodeficiency Syndrome, Cachexia, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡